Stock Analysis on Net

Johnson & Johnson (NYSE:JNJ)

Analysis of Liquidity Ratios

Microsoft Excel

Liquidity Ratios (Summary)

Johnson & Johnson, liquidity ratios

Microsoft Excel
Dec 29, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Current ratio 1.11 1.16 0.99 1.35 1.21
Quick ratio 0.78 0.82 0.71 1.04 0.91
Cash ratio 0.49 0.50 0.42 0.70 0.59

Based on: 10-K (reporting date: 2024-12-29), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

Liquidity ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. Johnson & Johnson current ratio improved from 2022 to 2023 but then slightly deteriorated from 2023 to 2024.
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. Johnson & Johnson quick ratio improved from 2022 to 2023 but then slightly deteriorated from 2023 to 2024.
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. Johnson & Johnson cash ratio improved from 2022 to 2023 but then slightly deteriorated from 2023 to 2024.

Current Ratio

Johnson & Johnson, current ratio calculation, comparison to benchmarks

Microsoft Excel
Dec 29, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Selected Financial Data (US$ in millions)
Current assets 55,893 53,495 55,294 60,979 51,237
Current liabilities 50,321 46,282 55,802 45,226 42,493
Liquidity Ratio
Current ratio1 1.11 1.16 0.99 1.35 1.21
Benchmarks
Current Ratio, Competitors2
AbbVie Inc. 0.66 0.87 0.96 0.79 0.84
Amgen Inc. 1.26 1.65 1.41 1.59 1.81
Bristol-Myers Squibb Co. 1.25 1.43 1.25 1.52 1.58
Danaher Corp. 1.40 1.68 1.89 1.43 1.86
Eli Lilly & Co. 1.15 0.94 1.05 1.23 1.40
Gilead Sciences Inc. 1.60 1.43 1.29 1.27 1.40
Merck & Co. Inc. 1.36 1.25 1.47 1.27 1.02
Pfizer Inc. 1.17 0.91 1.22 1.40 1.35
Regeneron Pharmaceuticals Inc. 4.73 5.69 5.06 3.56 3.63
Thermo Fisher Scientific Inc. 1.66 1.75 1.48 1.50 2.13
Vertex Pharmaceuticals Inc. 2.69 3.99 4.83 4.46 4.33
Current Ratio, Sector
Pharmaceuticals, Biotechnology & Life Sciences 1.24 1.27 1.30 1.36 1.37
Current Ratio, Industry
Health Care 1.11 1.13 1.15 1.21 1.20

Based on: 10-K (reporting date: 2024-12-29), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 2024 Calculation
Current ratio = Current assets ÷ Current liabilities
= 55,893 ÷ 50,321 = 1.11

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. Johnson & Johnson current ratio improved from 2022 to 2023 but then slightly deteriorated from 2023 to 2024.

Quick Ratio

Johnson & Johnson, quick ratio calculation, comparison to benchmarks

Microsoft Excel
Dec 29, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Selected Financial Data (US$ in millions)
Cash and cash equivalents 24,105 21,859 14,127 14,487 13,985
Marketable securities 417 1,068 9,392 17,121 11,200
Accounts receivable trade, less allowances 14,842 14,873 16,160 15,283 13,576
Total quick assets 39,364 37,800 39,679 46,891 38,761
 
Current liabilities 50,321 46,282 55,802 45,226 42,493
Liquidity Ratio
Quick ratio1 0.78 0.82 0.71 1.04 0.91
Benchmarks
Quick Ratio, Competitors2
AbbVie Inc. 0.43 0.63 0.69 0.56 0.60
Amgen Inc. 0.81 0.99 0.95 1.06 1.30
Bristol-Myers Squibb Co. 0.91 1.04 0.87 1.20 1.28
Danaher Corp. 0.83 1.18 1.30 0.89 1.36
Eli Lilly & Co. 0.59 0.52 0.63 0.80 0.85
Gilead Sciences Inc. 1.20 1.06 0.99 0.95 1.08
Merck & Co. Inc. 0.84 0.68 0.93 0.73 0.58
Pfizer Inc. 0.74 0.50 0.80 1.00 0.78
Regeneron Pharmaceuticals Inc. 3.86 4.82 4.16 2.98 2.86
Thermo Fisher Scientific Inc. 1.14 1.27 1.06 1.00 1.63
Vertex Pharmaceuticals Inc. 2.17 3.60 4.46 4.04 4.02
Quick Ratio, Sector
Pharmaceuticals, Biotechnology & Life Sciences 0.82 0.85 0.91 0.98 0.98
Quick Ratio, Industry
Health Care 0.80 0.82 0.86 0.89 0.89

Based on: 10-K (reporting date: 2024-12-29), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 2024 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= 39,364 ÷ 50,321 = 0.78

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. Johnson & Johnson quick ratio improved from 2022 to 2023 but then slightly deteriorated from 2023 to 2024.

Cash Ratio

Johnson & Johnson, cash ratio calculation, comparison to benchmarks

Microsoft Excel
Dec 29, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Selected Financial Data (US$ in millions)
Cash and cash equivalents 24,105 21,859 14,127 14,487 13,985
Marketable securities 417 1,068 9,392 17,121 11,200
Total cash assets 24,522 22,927 23,519 31,608 25,185
 
Current liabilities 50,321 46,282 55,802 45,226 42,493
Liquidity Ratio
Cash ratio1 0.49 0.50 0.42 0.70 0.59
Benchmarks
Cash Ratio, Competitors2
AbbVie Inc. 0.14 0.34 0.31 0.28 0.30
Amgen Inc. 0.52 0.60 0.59 0.66 0.91
Bristol-Myers Squibb Co. 0.46 0.55 0.42 0.78 0.83
Danaher Corp. 0.31 0.71 0.71 0.32 0.82
Eli Lilly & Co. 0.12 0.11 0.13 0.26 0.29
Gilead Sciences Inc. 0.83 0.64 0.57 0.56 0.65
Merck & Co. Inc. 0.48 0.28 0.54 0.34 0.30
Pfizer Inc. 0.48 0.27 0.54 0.73 0.47
Regeneron Pharmaceuticals Inc. 2.28 3.17 2.46 1.45 1.33
Thermo Fisher Scientific Inc. 0.42 0.58 0.50 0.33 1.00
Vertex Pharmaceuticals Inc. 1.72 3.16 3.93 3.51 3.55
Cash Ratio, Sector
Pharmaceuticals, Biotechnology & Life Sciences 0.45 0.47 0.52 0.58 0.59
Cash Ratio, Industry
Health Care 0.38 0.42 0.47 0.50 0.51

Based on: 10-K (reporting date: 2024-12-29), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 2024 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= 24,522 ÷ 50,321 = 0.49

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. Johnson & Johnson cash ratio improved from 2022 to 2023 but then slightly deteriorated from 2023 to 2024.